Intraplaque haemorrhages as the trigger of plaque vulnerability

Area of Science:

• Cardiovascular Biology
• Pathophysiology
• Medical Research

Background:

• Atherothrombosis is a leading cause of mortality, driven by factors like dyslipidemia, diabetes, and aging.
• Current treatments for atherothrombosis have limited success, indicating incomplete understanding of its pathophysiology.
• Increasing incidence of type 2 diabetes and aging contribute to high rates of clinical events.

Purpose of the Study:

• To explore emerging concepts in atherothrombosis pathophysiology.
• To investigate the role of intraplaque neovascularization and bleeding in disease progression.
• To highlight the implications of intraplaque hemorrhage for clinical practice.

Main Methods:

• Review of recent studies on atherothrombosis progression.
• Analysis of the role of intraplaque neovascularization and bleeding.
• Examination of intraplaque hemorrhage as a trigger for acute events.

Main Results:

• Intraplaque neovascularization and bleeding significantly contribute to plaque progression.
• These intraplaque events promote leukocyte infiltration.
• Intraplaque hemorrhage serves as a risk measure for future cardiovascular events.

Conclusions:

• Intraplaque hemorrhage is a critical event in triggering acute clinical events.
• Understanding intraplaque hemorrhage offers new avenues for therapeutic strategies.
• Advances in understanding intraplaque hemorrhage have implications for clinical research and practice.